B. Joy Snider's clinic focuses on early detection of memory issues, using biomarkers for precise Alzheimer's diagnosis and ...
A review of literature published over the last 5 years on ustekinumab in Crohn disease (CD) summarized 42 clinical studies on the efficacy and safety of ustekinumab products, including biosimilars, ...
The strength of an individual’s handgrip was associated with age-related macular degeneration (AMD) in a recent study, with incidence of AMD increasing in those with worse strength. 1 This result ...
Alcohol consumption, especially binge drinking, is a significant risk factor for breast cancer, with early-onset cases being particularly affected. Historical and recent studies consistently show ...
Producing the highest accuracy, the 9-gene set produced became the basis of the final classifier. When applied to multiple ...
There were no fatal treatment-emergent adverse events (TEAEs) in either patient group, but exposure-adjusted incidence rates ...
The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...
Clinicians and health system leaders met in Cleveland, Ohio, on October 23, 2025, to share improvements to value-based care ...
Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...
Discover more about seasonal affective disorder in this interview with Craig Sawchuk, PhD, LP, clinical psychologist at Mayo ...
Interventions reducing or eliminating diabetes medication costs showed variable impacts on adherence, with short-term improvements often diminishing over time. Combining cost-reduction strategies with ...
Four years of long-term data confirm the continued safety of the drug tildrakizumab in patients with psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results